A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer

This publication has 16 references indexed in Scilit:

• Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study
  Gut, 1997
• Plasma concentration of matrix metalloproteinase 9 in gastric cancer
  British Journal of Surgery, 1997
• Matrix metalloproteinase-7 expression in gastric carcinoma.
  Gut, 1996
• Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
  British Journal of Cancer, 1996
• Matrix Metalloproteinases in Brain Injury
  Journal of Neurotrauma, 1995
• Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits
  Inflammation Research, 1995
• Current Issues in Cancer: Is there an epidemic of cancer?
  BMJ, 1994
• Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.
  Journal of Clinical Oncology, 1994
• Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
  Journal of Neuroimmunology, 1992
• Metalloproteinases and their inhibitors in matrix remodeling
  Trends in Genetics, 1990